Stockreport

Acceleron Pharma up 7% on FDA nod for luspatercept [Seeking Alpha]

Acceleron Pharma Inc.  (XLRN) 
Last acceleron pharma inc. earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.acceleronpharma.com/investor-relations
PDF Acceleron Pharma up 7% on FDA nod for luspatercept Acceleron Pharma ( XLRN +7% CELG +0.4% announce The companies will co-promote the product in the U.S. [Read more]